SCTIMST performs its first LDL apheresis for Familial Hypercholesterolemia, dramatically lowering cholesterol in a 34-year-old patient.

Subhash Banerjee, MD (VA North Texas Health Care System & UT Southwestern Medical Center, Dallas), who presented the results of the PREMIER trial in a featured clinical research session at the annual ...

Sept. 4, 2003 — Editor's Note: Low-density lipoprotein (LDL) apheresis may benefit patients with persistent, symptomatic LDL cholesterol elevations or genetic LDL abnormalities refractory to medical ...

THIRUVANANTHAPURAM: In a major breakthrough, doctors at Sree Chitra Tirunal Institute for Medical Sciences and Technology ...

Drs Brinton and Michos highlight LDL-C apheresis in the treatment landscape for homozygous familial hypercholesterolemia [HoFH]. Eliot Brinton, MD: What do we do if the standard treatments don’t work?

Please provide your email address to receive an email when new articles are posted on . LAS VEGAS — LDL apheresis was safe and was linked to a trend toward early coronary atheroma regression in ...

A: Atorvastatin (mg/day); C: Colesevalam (g/day); E: Ezetimibe (mg/day); Lp aph: Lipoprotein apheresis; N: Nicotinic acid (g/day); P-P: Post-partum; Preg: Pregnancy ...

Patients who have heterozygous familial hypercholesterolemia (HeFH), a condition that causes abnormally raised low-density lipoprotein cholesterol (LDL-C) levels and premature cardiovascular disease, ...